pulmonaryfibrosisnews1d
The Los Angeles fires remind us to be prepared for emergencies
With idiopathic pulmonary fibrosis, columnist Sam Kirton continues to learn to be prepared for emergencies, such as the Los Angeles fires.
pulmonaryfibrosisnews5d
Blocking HIF2 protein may promote lung repair in IPF: Mouse study
Inhibiting the HIF2 protein was found to promote repair processes in a mouse model of lung injury, and may be a strategy for ...
pulmonaryfibrosisnews6d
My New Year’s wishes for the IPF community
As columnist Charlene Marshall looks ahead to 2025, she shares some of her New Year's wishes for fellow pulmonary fibrosis patients.
pulmonaryfibrosisnews8d
Keeping new year’s resolutions that affect pulmonary fibrosis
Columnist Sam Kirton believes in keeping new year's resolutions that help him manage his idiopathic pulmonary fibrosis.
pulmonaryfibrosisnews8d
Pulmonary Fibrosis News
Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.
pulmonaryfibrosisnews12d
Enzyme responsible for fatty acid may be IPF therapeutic target
Fatty acid synthase, the enzyme responsible for fatty acid production in cells, may be a therapeutic target for IPF, a mouse ...
pulmonaryfibrosisnews26d
Trial: LYT-100 better than Esbriet in slowing lung function decline in IPF
The investigational therapy LYT-100 (deupirfenidone) significantly slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF), outperforming the standard of care therapy Esbriet.